• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cost-benefit analysis of hepatitis-B vaccination.

作者信息

Lahaye D, Strauss P, Baleux C, van Ganse W

出版信息

Lancet. 1987 Aug 22;2(8556):441-3. doi: 10.1016/s0140-6736(87)90971-8.

DOI:10.1016/s0140-6736(87)90971-8
PMID:2887738
Abstract

Since 1983 the Belgian insurance Fund for Occupational Disease (FOD) has refunded the cost of hepatitis-B (HB) vaccination. Vaccination has been carried out by occupational physicians selectively on staff in hospitals and medical-care institutions. At the end of 1986, 40,000 people at high risk of HBV infection had been vaccinated. The vaccination costs are largely offset by the benefits resulting from the striking fall in the number of HB cases. The financial investment has proved economically beneficial for the insurance fund.

摘要

相似文献

1
Cost-benefit analysis of hepatitis-B vaccination.
Lancet. 1987 Aug 22;2(8556):441-3. doi: 10.1016/s0140-6736(87)90971-8.
2
[The costs of hepatitis B vaccination: a re-evaluation].
Ned Tijdschr Geneeskd. 1990 Feb 10;134(6):298-301.
3
Cost-effectiveness of hepatitis-B vaccine in Greece. A country of intermediate HBV endemicity.希腊乙型肝炎疫苗的成本效益。一个乙型肝炎病毒中等流行率的国家。
Int J Technol Assess Health Care. 1991;7(3):256-62. doi: 10.1017/s026646230000564x.
4
Occupational exposure to hepatitis B virus. Analysis of indications for hepatitis B vaccine.
J Occup Med. 1984 Mar;26(3):189-96.
5
Hepatitis B virus vaccine. Cost-benefit analysis of its use in a children's hospital.乙肝疫苗。在一家儿童医院使用的成本效益分析。
Clin Pediatr (Phila). 1989 Aug;28(8):359-65. doi: 10.1177/000992288902800805.
6
[A method for evaluating the hepatitis B vaccination program].
Ann Ist Super Sanita. 1989;25(2):337-43.
7
A simplified financial cost-effectiveness analysis of programs for prevention of hepatitis B accidental inoculation among hospital personnel in Thailand.泰国医院工作人员预防乙型肝炎意外接种项目的简化财务成本效益分析
Southeast Asian J Trop Med Public Health. 1989 Jun;20(2):189-93.
8
[Cost-benefits of vaccination against hepatitis B in hospital personnel in Venezuela].
Bol Oficina Sanit Panam. 1991 Jul;111(1):16-23.
9
A 1992 update on hepatitis B vaccination.1992年乙型肝炎疫苗接种最新情况。
J Can Dent Assoc. 1992 Jul;58(7):569-70.
10
[Immunization against hepatitis B].
Av Odontoestomatol. 1986 Nov-Dec;2(6):303-5, 307-9.

引用本文的文献

1
Economic evaluation of HBV vaccination: A systematic review of recent publications (2000-2013).乙肝疫苗接种的经济学评估:对近期出版物(2000 - 2013年)的系统评价
Hum Vaccin Immunother. 2016 Sep;12(9):2299-311. doi: 10.1080/21645515.2016.1166328. Epub 2016 Apr 22.
2
The estimation of direct medical costs of treating patients with chronic hepatitis B and C in iran.伊朗慢性乙型和丙型肝炎患者治疗的直接医疗费用估算。
Int J Prev Med. 2012 Mar;3(3):191-6.
3
Risk factors for hepatitis B virus infection in Rio de Janeiro, Brazil.巴西里约热内卢乙型肝炎病毒感染的危险因素。
BMC Public Health. 2002 Nov 22;2:26. doi: 10.1186/1471-2458-2-26.
4
The economic burden of hepatitis B in Germany.德国乙型肝炎的经济负担。
Eur J Epidemiol. 2000 Feb;16(2):173-7. doi: 10.1023/a:1007624415699.
5
Therapeutic conservatism: more costly in the long term? A UK perspective.治疗保守主义:从长远来看成本更高?英国视角。
Pharmacoeconomics. 1995 May;7(5):378-87. doi: 10.2165/00019053-199507050-00002.
6
Pharmacoeconomics of immunisation: a review.免疫接种的药物经济学:综述
Pharmacoeconomics. 1993 Apr;3(4):286-308. doi: 10.2165/00019053-199303040-00005.
7
Hepatitis B vaccine: a pharmacoeconomic evaluation of its use in the prevention of hepatitis B virus infection.乙肝疫苗:对其预防乙肝病毒感染应用的药物经济学评估
Pharmacoeconomics. 1994 Feb;5(2):141-71. doi: 10.2165/00019053-199405020-00008.
8
Hepatitis B and hepatitis delta virus infection in South America.南美洲的乙型肝炎和丁型肝炎病毒感染
Gut. 1996;38 Suppl 2(Suppl 2):S48-55. doi: 10.1136/gut.38.suppl_2.s48.
9
Cost-benefit analysis of a nationwide neonatal inoculation programme against hepatitis B in an area of intermediate endemicity.中等流行地区全国性新生儿乙型肝炎免疫接种计划的成本效益分析。
J Epidemiol Community Health. 1992 Dec;46(6):587-94. doi: 10.1136/jech.46.6.587.
10
Cost-benefit analysis of a nationwide inoculation programme against viral hepatitis B in an area of intermediate endemicity.中等流行地区全国性乙型病毒性肝炎接种计划的成本效益分析。
Bull World Health Organ. 1992;70(6):757-67.